Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
GeneCast logo — Advanced cancer detection and personalized treatment through...

GeneCast

Advanced cancer detection and personalized treatment through groundbreaking technology that targets only mutated genes.

Founded 2016 Series B Total: $19.50B Health Care

General Information

Company Name GeneCast
Founded Year 2016
Industries Health Care
Funding Stage Series B
Social

Get notified when GeneCast moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About GeneCast

GeneCast is a Health Care startup founded in 2016, with a focus on advanced cancer detection and personalized treatment. Their groundbreaking technology targets only mutated genes, offering cancer screening, monitoring, precision care, and accompanying diagnosis through source technology that amplifies only mutated genes. The company recently secured a remarkable KRW14.30B Series B investment on 08 June 2020, attracting a group of prominent investors including Partners Investment, Timewise Investment, PNP Investment, KDB Capital, KB Securities, DK&D, Green Cross Medical Science, and Green Cross. GeneCast's innovative approach to cancer detection and treatment makes it a compelling prospect for potential investors seeking opportunities in the healthcare technology sector.

Taxonomy: cancer detection, personalized treatment, groundbreaking technology, mutated genes, precision care, cancer screening, diagnosis, advanced technology, genetic testing

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 8
Investor Investor Investor Investor Investor
•••• •••• 		08 Jun 2020
Series A •••••• 2 •••• •••• 09 May 2018
Series A •••••• - 04 Apr 2018

GeneCast Alternatives & Competitors

GeneCast vs
Anviron
Anviron United States

"Targeting the Cancer Glycobiome."

Non Equity Assistance
2 employees
Health Care, Health and Wellness
GeneCast vs
Lucence
Lucence United States

Overcoming cancer through earlier detection

Series A
111 employees
Biotechnology, Health Care
GeneCast vs
Seno Medical
Seno Medical United States

Groundbreaking diagnostic imaging for breast cancer using a novel combination of ultrasound and opto...

Series C
49 employees
Health Care, Medical Devices

FAQ About GeneCast

Advanced cancer detection and personalized treatment through groundbreaking technology that targets only mutated genes.
GeneCast was founded in 2016.
GeneCast operates in the following industries: Health Care.
GeneCast has completed 3 funding rounds, raising a total of $19.50B. The latest funding stage is Series B.
Top alternatives and competitors to GeneCast include Anviron, Lucence, Seno Medical, NCC Korea, C the Signs. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GeneCast and Anviron are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors GeneCast and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy